Emetogenicity and myelosuppression profile

John describes ifosfamide as moderately emetogenic with typical myelosuppression nadir around ten days.

Play episode from 07:49

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!